Bephenium Hydroxynaphthoate
CAS No. 3818-50-6
Bephenium Hydroxynaphthoate( —— )
Catalog No. M14321 CAS No. 3818-50-6
Bephenium hydroxynaphthoate (INN, trade names Alcopara, Alcopar, Befenium, Debefenium, Francin, Nemex) is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 28 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBephenium Hydroxynaphthoate
-
NoteResearch use only, not for human use.
-
Brief DescriptionBephenium hydroxynaphthoate (INN, trade names Alcopara, Alcopar, Befenium, Debefenium, Francin, Nemex) is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis.
-
DescriptionBephenium hydroxynaphthoate (INN, trade names Alcopara, Alcopar, Befenium, Debefenium, Francin, Nemex) is an anthelmintic agent formerly used in the treatment of hookworm infections and ascariasis.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number3818-50-6
-
Formula Weight443.53
-
Molecular FormulaC28H29NO4
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESOC(=O)C1=CC2=CC=CC=C2C=C1[O-].C[N+](C)(CCOC1=CC=CC=C1)CC1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.MEHROTRA MP, MALAVIYA US. Indian J Med Sci. 1963 Dec;17:930-3.
molnova catalog
related products
-
NLS-StAx-h
Wnt inhibitor (IC50 = 1.4 μM). Stapled peptide inhibitor of oncogenic Wnt signaling. Inhibits β-catenin-transcription factor interactions. Inhibits proliferation and migration of colorectal cancer cells. Cell permeable.
-
KL044
KL044 is a cryptochrome 1 (CRY1) activator that prolongs circadian rhythms and inhibits PER2 activity. KL044 inhibits melanogenesis by inhibiting the cAMP/PKA/CREB pathway.
-
GSK2033
GSK2033 is an antagonist of LXR (pIC50s: 7 and 7.4 for LXRα or LXRβ, respectively).
Cart
sales@molnova.com